Skip to main content

H.R. 7132

Referred to Committee

Never Again International Outbreak Prevention Act

Introduced 6/8/2020•116th Congress•House

Latest Action

Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, the Judiciary, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

6/8/2020 • House

Summary

Never Again International Outbreak Prevention Act

This bill establishes measures related to international accountability for outbreaks of novel viruses and diseases.

The Department of State must establish lists of countries based on the procedures and standards each country has implemented to (1) identify outbreaks and monitor diseases, and (2) ensure that novel viruses and diseases are timely reported.

The President must take specified action with respect to countries that are deemed capable of implementing such procedures and standards but have not done so. The President may also sanction government officials of such countries.

Foreign state sovereign immunity is waived in any case seeking damages against a foreign state for (1) injury or death in the United States caused by a state's failure to abide by such procedures and standards, or (2) intentionally misleading the international community or the World Health Organization (WHO) regarding the outbreak or spread of a health concern that leads to a pandemic.

The President must facilitate (1) an international investigation and report on the response to COVID-19 (i.e., coronavirus disease 2019), and (2) an international audit of the WHO relating to its actions in response to COVID-19.

The U.S. Representative to the United Nations (U.N.) must request that the U.N. (1) review the WHO's response to COVID-19, and (2) recommend actions to improve future responses and ensure WHO accountability for identified failures. The Representative shall seek a global ban on wet markets (markets where animals of uncertified origin and health are sold in unhygienic conditions, dead or alive, for human consumption).

Introduced in House • 6/8/2020

Enter your district to see how this bill affects your community
-

Topics & Subjects

Accounting and auditingAgricultural marketing and promotionAnimal and plant healthAnimal protection and human-animal relationshipsCardiovascular and respiratory healthCivil actions and liabilityCongressional oversightDiplomacy, foreign officials, Americans abroadEmergency medical services and trauma careForeign aid and international reliefForeign loans and debtForeign propertyGovernment information and archivesGovernment liabilityGovernment studies and investigationsHealth information and medical recordsInfectious and parasitic diseasesInternational organizations and cooperationJurisdiction and venue

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (2)

Party Breakdown

1
Democrats
1
Republicans
0
Independents

Sponsor

R[
Rep. Fitzpatrick, Brian K. [R-PA-1]

Republican • PA-1

Sponsored 6/8/2020

Cosponsors (1)

R[
Rep. Lamb, Conor [D-PA-17]

D-PA-17

Joined 6/8/2020

Bill Journey

Originated in the House

Introduced

June 8, 2020

Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, the Judiciary, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House6/8/2020

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors1